steady-state in patients [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2024-12-17 10:45 (195 d 18:35 ago) – Posting: # 24319
Views: 3,934

Hi Christian,

of course, multiple dose studies are recommended in patients where the treatment cannot be interrupted.
However, Libaiyi asked in his post about steady-state as a means to reduce variability. That is not acceptable.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,681 registered users;
57 visitors (0 registered, 57 guests [including 11 identified bots]).
Forum time: 06:21 CEST (Europe/Vienna)

Fools with Tools Are Still Fools!    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5